[
    [
        {
            "time": "",
            "orginal_text": "26亿美安进连并两家biotech，背后逻辑是什么？又与中国药企有怎样的联系？",
            "features": {
                "keywords": [
                    "安进",
                    "biotech",
                    "并购",
                    "中国药企"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "26亿美安进连并两家biotech，背后逻辑是什么？又与中国药企有怎样的联系？",
            "scores": {
                "News_content": "26亿美安进连并两家biotech，背后逻辑是什么？又与中国药企有怎样的联系？",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "海外策略｜海外“全中国组合” — 2021年4月",
            "features": {
                "keywords": [
                    "海外策略",
                    "全中国组合",
                    "2021年4月"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "海外策略｜海外“全中国组合” — 2021年4月",
            "scores": {
                "News_content": "海外策略｜海外“全中国组合” — 2021年4月",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "orginal_text": "中信证券：3月A股、港股延续节后调整 没看到资金流出新兴市场",
            "features": {
                "keywords": [
                    "中信证券",
                    "A股",
                    "港股",
                    "调整",
                    "资金流出",
                    "新兴市场"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "中信证券：3月A股、港股延续节后调整 没看到资金流出新兴市场",
            "scores": {
                "News_content": "中信证券：3月A股、港股延续节后调整 没看到资金流出新兴市场",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "orginal_text": "医药行业一周观察：调整后重归均衡 关注内生成长明确的一二线公司",
            "features": {
                "keywords": [
                    "医药行业",
                    "调整",
                    "均衡",
                    "内生成长",
                    "一二线公司"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药行业一周观察：调整后重归均衡 关注内生成长明确的一二线公司",
            "scores": {
                "News_content": "医药行业一周观察：调整后重归均衡 关注内生成长明确的一二线公司",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "一文看懂为何近期医疗服务、医美标的股价反弹涨幅较大",
            "features": {
                "keywords": [
                    "医疗服务",
                    "医美",
                    "股价反弹",
                    "涨幅"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "一文看懂为何近期医疗服务、医美标的股价反弹涨幅较大",
            "scores": {
                "News_content": "一文看懂为何近期医疗服务、医美标的股价反弹涨幅较大",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "医药行业2021年4月投资策略：业绩驱动渐入佳境",
            "features": {
                "keywords": [
                    "医药行业",
                    "2021年4月",
                    "投资策略",
                    "业绩驱动"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药行业2021年4月投资策略：业绩驱动渐入佳境",
            "scores": {
                "News_content": "医药行业2021年4月投资策略：业绩驱动渐入佳境",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 4,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        }
    ]
]